Clinical & Interventional Cardiology

Transcription

1 Endorsed by CATANIA APRIL ITALY Clinical & Interventional Cardiology President: Michele M. Gulizia, MD, FESC PRELIMINARY PROGRAM 1

2 Dear Colleagues and Friends, I would like to invite you to attend the 7th edition of the Mediterranean Cardiology Meeting (MCM), April 18-20, in Catania (Italy). Over 1200 participants attended our last meeting with also strong international participation which confirmed the highest interest aroused by this biannual meeting. An outstanding Faculty, selected between the leading experts on these fields, will provide the highest quality teaching with new interactive programs and happenings. Thorough multidisciplinary Courses, Symposia, Debates on Controversial Topics, Clinical Tutorials, Luncheon Panels, Focus on, Meet-the-Expert Sessions, Interactive Cases-Review from Faculty and Attendance, Televoter Sessions, Intercultural Exchanges, Abstract and Poster Sessions the meeting will highlight the current state and the prospective developments for the treatment of: Atrial Fibrillation, Sudden Cardiac Death, Heart Failure, Acute Coronary Syndromes, Global Cardiovascular Prevention, Arterial Hypertension, Pharmacological Therapy, Syncope, Congenital Heart Disease, Cardiac Monitoring Technologies and Genetics. The main target of the meeting is to give the latest update on Clinical & Interventional Cardiology and it is addressed to cardiologists, internists, first aid clinicians, physicians of general medicine, fellows, nurses and technicians with high interest in the whole management of cardiac pathologies. Catania, as one of the most famous historical and cultural locations in the whole Mediterranean area, is the ideal setting for this meeting. It is a particularly lively and fascinating town, rich in marvellous examples of typically Sicilian baroque style, as well as one of the main economic and educational centres in the island, and a key hub of the technological industry. This beautiful city, full of colours, perfumes and flavours, is suspended between the deep blue of the Ionian Sea and the majestic shape of Etna volcano, which dominates the town from afar. Looking forward to seeing you in Catania, sincerely Michele M. Gulizia, MD, FESC President Mediterranean Cardiology Meeting 2 3

3 Updated on August 1 st 2014 CATANIA APRIL ITALY Scientific Committee Angelo Auricchio (Switzerland) Gianluca Botto (Italy) Eugene Braunwald (USA) Michele Brignole (Italy) Joseph Brugada (Spain) Riccardo Cappato (Italy) Paul Casale (USA) Matteo Di Biase (Italy) Giuseppe Di Pasquale (Italy) Bulent Gorenek (Turkey) Michele M. Gulizia (Italy) Karl Heinz Kuck (Germany) Organizing Committee Michele M. Gulizia Concetto Cacia Nunzia R. Cardillo Giuseppe Di Guardo Giuseppina Maura Francese Daniele Mangiameli Cardiology Division Ga r i b a l d i Ne s i m a Ho s p i ta l Cata n i a, Ita ly Advisory Board (provisional) Maurizio Abrignani (Italy) Gianfranco Alunni (Italy) Antonio F. Amico (Italy) Fabrizio Ammirati (Italy) Angelo Auricchio (Switzerland) Alessandro Biffi (Italy) Giuseppe Boriani (Italy) Gianluca Botto (Italy) Francesco Maria Bovenzi (Italy) Michele Brignole (Italy) Joseph Brugada (Spain) Pasquale Caldarola (Italy) Valeria Calvi (Italy) Salvatore Campione (Italy) Roberto Caporale (Italy) Riccardo Cappato (Italy) Paul Casale (USA) Giancarlo Casolo (Italy) Domenico Catanzariti (Italy) Giacomo Chiarandà (Italy) Gennaro Cice (Italy) Furio Colivicchi (Italy) Pietro Delise (Italy) Matteo Di Biase (Italy) Andrea Di Lenarda (Italy) Giuseppe Di Pasquale (Italy) Giuseppe Di Tano (Italy) Francesco Furlanello (Italy) Domenico Gabrielli (Italy) Angelo Gambera (Italy) Gianfranco Gensini (Italy) Giovanna Geraci (Italy) Franco Giada (Italy) Bulent Gorenek (Turkey) Michele M. Gulizia (Italy) Giuseppe Inama (Italy) Helmut Klein (Germany) Karl Heinz Kuck (Germany) Maurizio Eugenio Landolina (Italy) Aldo P. Maggioni (Italy) Attilio Maseri (Italy) Jay Metha (USA) Andrea Natale (USA) Ali Oto (Turkey) Eli I. Ovsyshcher (Israel) Fausto J. Pinto (Portugal) Antonio Raviele (Italy) Renato Pietro Ricci (Italy) Francesco Romeo (Italy) Massimo Santini (Italy) Marino Scherillo (Italy) Anna Portale Salvatore Raciti Natascia Savoca Silvana Anastasi Giuseppe Di Dio Giuditta Gianì Maurizio Lunati (Italy) Aldo Pietro Maggioni (Italy) Attilio Maseri (Italy) Anna Vittoria Mattioli (Italy) Gianfranco Mazzotta (Italy) Jay Metha (USA) Vincenzo Montemurro (Italy) Loredana Morichelli (Italy) Ernesto Mossuti (Italy) Franco Naccarella (Italy) Federico Nardi (Italy) Andrea Natale (USA) Salvatore Novo (Italy) Ali Oto (Turkey) Eli I. Ovsyshcher (Israel) Giuseppe Palazzo (Italy) Vittorio Panno (Italy) Leonardo Patanè (Italy) Pasquale Perrone Filardi (Italy) Fausto J. Pinto (Portugal) Salvatore Pirelli (Italy) Calogero Puntrello (Italy) Antonio Raviele (Italy) Renato Pietro Ricci (Italy) Carmine Riccio (Italy) Carla Riganti (Italy) Francesco Romeo (Italy) Massimo Santini (Italy) Maurizio Santomauro (Italy) Marino Scherillo (Italy) Gianfranco Sinagra (Italy) Christian Sticherling (Switzerland) Corrado Tamburino (Italy) Pier Luigi Temporelli (Italy) Sakis Themistoclakis (Italy) Salvatore Tolaro (Italy) Giovanni Battista Zito (Italy) Massimo Zoni Berisso (Italy) Guerrino Zuin (Italy) Allied Professionals Course Coordinators Giuseppina Maura Francese (Italy), Angelo Gambera (Italy), Loredana Morichelli (Italy) Endorsed by: 4 5 ENDORSEMENT & AUSPICES EHRA - European Heart Rhythm Association, a Registered Branch of the ESC FIC - Federazione Italiana di Cardiologia WSA - World Society of Arrhythmias Under the auspices of: AIAC - Associazione Italiana di Aritmologia e Cardiostimolazione ANCE - Associazione Italiana Cardiologi Extraospedalieri ANMCO - Associazione Nazionale Medici Cardiologi Ospedalieri ARCA - Associazioni Regionali Cardiologi Ambulatoriali AA Arrhythmia Alliance ECAS - European Cardiac Arrhythmia Society GIEC - Gruppo Intervento Emergenze Cardiologiche GISE - Società Italiana di Cardiologia Invasiva ISE - International Society of Electrocardiology SIC - Società Italiana di Cardiologia SIC SPORT - Società Italiana di Cardiologia dello Sport SOLAECE - Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia

4 PROGRAM AT A GLANCE Saturday, April 18 Sat, April 18 PEGASO Room ETNA Room CALIPSO Room Timo Alto Room Registration Registration Allied Professional Registration Registration Minicourse Electrical Cardioversion in patients treated by NAO Interactive Minicourse Risk Stratification in Primary Prevention Exhibition Visit & Coffee Break Exhibition Visit & Coffee Break Focus on Arrhythmias & Device Controversies on Dronedarone: Guide Lines and Therapeutic Plan, a glaring dichotomy between Clinical Evidences and Regulatory restrictions Interactive Symposium The management of the patient with Stable CAD: the benefits of the new therapeutic approach Allied Professional Program Nursing management of cardiovascular drugs Allied Professional Program Organizational aspects and management in arrhythmology - Nursing in hemodynamic Casual Morning Meeting Management of our patients in Daily Clinical Practice: how to select candidates to ECHO, MRI, TC Casual Morning Meeting Navigating the evidence: are all NOACs the same? Luncheon Panel Exhibition Visit & Coffee Break ESC-EHRA Joint Symposium Interactive Luncheon Panel Different therapeutical approach in patients with NSTEMI PCI and in those with pharmacological therapy Interactive Symposium Rivaroxaban: practical experience examples and sharing clinical cases Luncheon Panel Allied Professional Program Update In Electrophysiology And Cardiac Pacing Plenary Lecture Allied Professional Program Prevention of infection in cardiology and cardiac surgery Opening Ceremony 6 7

5 PROGRAM AT A GLANCE Sunday, April 19 Sun, April 19 PEGASO Room ETNA Room CALIPSO Room Timo Alto Room Minicourse Heart Failure with Preserved Ejection Fraction: how to manage it? Exhibition Visit & Coffee Break Satellite Symposium Getting the most out of the latest available technologies in order to optimize daily clinical practice M. Lecture tbd Interactive Symposium Management of dyslipidemia in high cardiovascular risk patients: two clinical cases Interactive Symposium Unmet needs and current practice of stroke prevention in non valvular atrial fibrillation Allied Professional Program NAO in nonvalvular atrial fibrillation Exhibition Visit & Coffee Break Allied Professional Program Joint Session: Education as a tool to enhance the health care allied professionals - Nurse and heart failure Casual Morning Meeting Longevity, Mini-ICD, S-ICD: the right device for every patient. What is the best choice? Casual Morning Meeting Rivaroxaban: operating instructions SJ. Luncheon Panel tbd Interactive Luncheon Panel Exhibition Visit Exhibition Visit Symposium The Use of large Registries for Quality Improvement for patients with Coronary Artery Disease or Cardiac Arrhythmias Lecture Thyroid hormone treatment in heart failure: when and how? Interactive Symposium Novel trials and new horizons with dabigatran: protecting patients at high risk of stroke Allied Professional Program Nursing care in non-invasive ventilation Lecture A defibrillator to bring down mortality: state of the art (S-ICD) Casual Afternoon Meeting Beyond LDL cholesterol control Lecture Inflammation in atherosclerosis- do we need to treat it? Meet the Expert The Heart in Neoplastic patients Interactive Meet the Expert 10 Interactive Question / Answers on Pulmonary Hypertension & Pulmonary Embolism 8 9

6 PROGRAM AT A GLANCE Monday, April 20 Mon, April 20 PEGASO Room ETNA Room CALIPSO Room Timo Alto Room Minicourse TAVI and MITRACLIP: how to select the Ideal Candidate Interactive Minicourse Pediatric Cardiology: the real needs for daily practice Exhibition Visit & Coffee Break Exhibition Visit & Coffee Break Symposium Which Antiplatelet Agent in the treatment of SCA patients? Focus on Chest Pain: do we still need a CP Unit or can we integrate it in Cardiology? Interactive Symposium Heart & Sport: 10 Question / Answers on Cardiac Evaluation at Different Age and Different Sports Lecture Changing the face of anticoagulation: 2 years of Dabigatran in Italy BLS-D Course physician BLS-D Course physician Casual Morning Meeting New perspectives in the prevention of thromboembolic risk in Atrial Fibrillation Luncheon Panel Interactive Luncheon Panel Lunch Symposium Endocarditis, Miocarditis, Pericarditis & surrounds: how is changed the clinical approach to this patient Focus on ICD implanted patients: balance between Benefit & Complication Interactive Symposium Atrial Fibrillation & Heart Failure Interactive Focus On Do we need Cardiopulmonary Test in All Heart Failure patients? BLS-D Course physician 10 11

7 MAIN TOPICS CATANIA APRIL Clinical Cardiology Epidemiology and risk stratification in healthy and sick population Expanding the target population for anti-platelet/coagulation therapy Controversial issues: from clinical studies to real life Sport and cardiac pathologies Nuclear cardiology in CAD and CHF patients Acute Coronary Syndromes Management of STEMI and non-stemi patient Evolving therapies for Acute myocardial Infarction: when PTCA, when stent? Hybrid myocardial revascularization Post-ACS patient s route Anti-thrombotic therapy in STEMI and NSTEMI patient Fibrinolitics, IIb/IIIa inhibitors: a therapy beyond any expectation? New antiplatelet drugs Spinal Cord Stimulation in refractory CAD: the last resource? Global Cardiovascular Risk Prevention Global Cardiovascular Risk assessment and prevention Insulin Resistance Syndrome, type 2 Diabetes and Atherosclerosis: an explosive mixture Lipid-lowering therapy: do we need statins for all life long? Role of platelets in the atherosclerosis pathogenesis Drug interaction, gender, age and comorbidities Elderly and Cardiology: are all patients to be treated the same way? Right pharmacological therapy in fragile patient 12 13

8 MAIN TOPICS CATANIA APRIL ITALY Clinical Arrhythmology Atrial Fibrillation New insight into the electrophysiological mechanism of AF initiation and perpetuation The ionic bases underlying the trigger of AF New experimental drugs for the treatment of recurrent AF Limitations of current guidelines for anticoagulation in AF The prevalence and clinical significance of silent AF Role of drug therapy in the prevention of recurrence of AF New drugs for stroke prevention New oral anticoagulants Atrial Fibrillation in children Echocardiography Echocardiography in the evaluation of the induced AF-mechanical remodelling Evaluation of thromboembolic atrial sources Echo optimisation of atrial-ventricular delay in paced AF patients Doppler echocardiography in the management of the resynchronization in HF Genetic Arrhythmias Guidelines in Cardiology Heart Failure The interaction of AF and CHF and its clinical implications Neurohumoral activation in CHF patients Latest pharmacological therapy for CHF The HF doctor: is there still a role for clinical cardiologists? What lessons from the early completed trials? Management of hypertrophic and dilated cardiomyopathy Hypertrophic Cardiomyopathy Non-Invasive Risk Stratification New non-invasive markers for risk stratification Sudden Death Results of ten year experience of Cardiac AED Resuscitation programs Advances in the prevention of SCD with non-antiarrhythmic drugs Home defibrillation strategy in high risk patients Syncope Syncope: practical issues of diagnosis and treatment Physical treatment of neurally-mediated syncope Organizational models of Syncope Unit Modern management of chest pain and unexplained palpitations The new generation implantable loop recordersili 14 15

9 MAIN TOPICS CATANIA APRIL ITALY Interventional Cardiology Trans-Catheter Ablation Supraventricular Arrhythmias Efficacy and safety of drug therapy vs trans-catheter ablation for atrial flutter Pulmonary Veins anatomy variability Ablation of AF in Pulmonary and Non-Pulmonary Foci Circumferential PV isolation: morbidity, mortality, QoL and long term outcomes The efficacy and safety of the cryosurgical maze procedure for refractory AF Ablation of Atrial Flutter Ventricular Arrhythmias Percutaneous trans-catheter ablation of ventricular arrhythmias How to manage non-inducibility Setting anti-tachypacing algorithms after ablation Implantable Pacing Device Latest indication to Cardiac Pacing Leadless pacemaker Left ventricle endocardial cardiac pacing New Pacing, Prevention and Cardioversion algorithms Latest pacing and ICD leads technology Telemedicine for the home follow-up of PM/ICD patients New generation of implantable cardiac haemodynamic sensors MR-conditional pacemaker systems Cost-effectiveness of drug/devices interaction Heart Failure & Cardiac Resynchronization Hybrid therapy in CHF and AF The optimal candidates to biventricular pacing Complication of biventricular pacing Optimizing CRT vector selection ICD backup in biventricular paced CHF patients need of multiples therapy in a single device Fluid & Congestion monitoring Supraventricular Arrhythmias Drug-device interaction in the management of pacing, prevention and treatment of atrial tachyarrhythmias New atrial tachyarrhythmias detection algorithms Implantable Defibrillators Electrical or chemical implantable atrial defibrillator: always fancy or a new tool? Is there a role for atrial ICD or is dual ICD enough? New physiological ICD therapies Primary Prevention of Sudden Cardiac Death in different population Remote monitoring devices New MR-conditional implantable defibrillators New generation Subcutaneous ICD Hemodynamical & Surgical Therapies New surgical strategies for AF Surgical transepicardic approach to CRT Role of surgery in end-stage CHF The treatment of ischemic mitral valve TAVI MITRACLIP Basic Cardiology & New Frontiers New developments in cardiac imaging Data-banks in cardiology: an useful tool in the follow-up Genetics, arrhythmogenesis and cardiomyopathies Cellular and molecular mechanism of conduction disease and apoptosis Update on Guidelines in Cardiology Late-breaking and on-going clinical trials 16 17

10 REGISTRATION INFORMATION Individual Registration Participants are invited to register using the on-line service on the web site: mcmweb.it. Alternately, the form can be downloaded from the web site and faxed to the Organizing Secretariat. The registration will be confirmed only if accompanied by the payment. Course Attendance Modalities BLS-D COURSE PHYSICIAN Before November 30th 2014 From December 1st ,00* Vat 22% not included 220,00* Vat 22% not included Group Registration Companies have the opportunity to sponsor the registration of a group of participants by contacting the Organizing Secretariat, Adria Congrex (booking@mcmweb.it). A group consists of a minimum of 10 participants. Registration shall be coordinated by one identified contact person representing a pharmaceutical/product company or a travel agency. Congress Registration Modalities DELEGATE Before November 30th ,00* Vat 22% not included From December 1st ,00* Vat 22% not included Registration fee includes: attendance to all the scientific sessions including the luncheon panels (limited to seat availability), entrance to the exhibition area, meeting proceedings, attendance certificate, badge and congress kit, welcome opening reception and coffee breaks at the Venue, CME Certificate (for Italian participants). Registration fee includes: participation to the Course, entrance to the exhibition area, BLS-D licence, coffee break, CME Certificate (for Italian participants). Maximum 36 participants accepted on first come first served basis after the full payment of the charge. Date and timetables must be respected. ALLIED PROFESSIONAL REGISTRATION Registration for 1 day 60,00* Vat 22% not included Registration for 2 days 100,00* Vat 22% not included Registration fee includes: attendance to all scientific sessions including luncheon panel, entrance to the exhibition area, badge and conference kit, attendance certificate, CME certificate (if entitled to - two-day attendance is required), coffee breaks and welcome opening ceremony. * VAT could be subjected to changes. The VAT rate will be applied depending on the Italian fiscal law at the time of payment of registration. AFTER APRIL 10th, ALL REGISTRATIONS CAN BE MADE ON SITE 18 19

11 SCIENTIFIC INFORMATION Abstract Submission DEADLINE: JANUARY 9 th, Abstracts can only be submitted on-line on and worded in English. You can find all the instructions on the website. The presentation of an abstract requires the registration of at least one of the authors. The Scientific Committee will review all the submitted abstracts and the selected ones will be accepted as oral communications or posters. The abstract authors will receive notification of acceptance by February 13, together with the information regarding their presentation. All the accepted abstracts (if the presenter is regularly registered within February 27, ) will be printed in a book available at the time of the Congress. There will be special awards given to THE BEST COMMUNICATIONS selected by the Scientific Committee among accepted oral communications and posters. Projection PC data projection will be available in all the rooms. All projections must be worded in English only. Luncheon Panels The admission to the luncheon panels (limited to seat availability) is free for all the registered participants. Attendance Certificates Attendance certificates will be distributed to all the registered delegates at the end of the Meeting. Program Changes The information published in this program is correct at time of print. The Scientific Committee reserves the right to change the program at any time

12 LOCATION CATANIA APRIL ITALY Catania & Congress Venue Catania is undoubtely one of the most important cities in the whole Mediterranean area, both in terms of cultural and historical point of view. It is one of the few cities in Italy that offers a variety of landscapes condensed in one site. Located on the east coast of Sicily (which represents the metropolitan area with the highest population density), Catania has ancient origins since its foundation dates back to 729 BC. During its history Catania has been a constant point of reference for the entire Mediterranean area, especially from an artistic and cultural point of view: it is here that in 1434 the oldest university of Sicily was founded. The remains of several ruins still enrich the heritage of the town and surrounding areas, despite Catania was repeatedly destroyed by violent volcanic eruptions caused by the Etna volcano (the most impressive occurred in 1669) and by devastating earthquakes (the more catastrophic one occurred in 1693). It is from this tragic event that the city and its people were able to get up in a truly unique and admirable way. A work of reconstruction with few equals in the world led to the blossoming of the famous Sicilian Baroque style of architecture that identifies more than any other the fantasy, the imaginative power and the passion for beauty of Catania and its inhabitants. Therefore in 2006 the splendid baroque center of Catania became a UNESCO World Heritage Site, along with seven towns of the Val di Noto, Sicily. Today, Catania is a city full of colors, scents and flavors - a lively and surprising, suspended between the magic of the blue Ionian Sea and the imposing outline of Etna volcano and often snowy, which dominates the city from above. Sheraton Catania Hotel & Conference Center Just few minutes from the historic center of Catania, the Sheraton Hotel offers high level of hospitality with a wide range of business and spare time facilities. The Sheraton Catania is one of the largest conference centers in eastern Sicily, with an area of 724 square meters in 6 modular meeting rooms of different sizes and acoustically isolated. All the 162 rooms and 7 suites - walking through a panoramic elevator - are characterized by colors that come into perfect harmony with the landscape of the Mediterranean area. Each room is equipped with all facilities and comforts offering the highest standards of quality and safety. The conference area, personalized for the Mediterranean Cardiology Meeting, provides a great learning experience in an extremely pleasant and comfortable site

13 HOTEL ACCOMMODATION The hotel reservation form can be filled out on line on the web site: www. mcmweb.it. Alternately, the form can be downloaded from the web site and faxed to the Organizing Secretariat. It is strongly recommended to book well in advance. Adria Congrex will make every effort to place you in the hotel category of your choice. A confirmation will be sent starting from March. Please note that hotel categories and rooms are assigned on a first come first served basis. Hotel reservation can be made by: Sending your credit card details to be used as a guarantee. The total amount will be paid to the hotel at the check out. Rates* Double room as single use Double room 5 Star Hotels ***** 1) Romano Palace 146,50 183,00 4 Star Hotels **** 2) Aga Hotel 136,50 158,00 3) Grand Hotel Baia Verde 131,50 153,00 4) Liberty 110,50 153,00 5) Nettuno 131,00 165,00 6) NH Parco degli Aragonesi 110,50 137,00 7) Romano House 131,50 163,00 8) Una Hotel Palace 171,50 198,00 3 Star Hotels *** 9) Best Western Mediterraneo 100,50 112,00 Contracted hotels provisional list * All prices include: taxes, VAT, service, continental breakfast and are per room per night. Transfer service is not available

14 SPONSORSHIP (Main sponsor updated on August 2014) CATANIA APRIL ITALY A. Menarini Astrazeneca Bayer BMS - Pfizer Boehringer Ingelheim Boston Scientific Daiichi Sankyo IBSA Medico Medtronic MSD Sanofi St Jude Medical 26 27

15 ORGANIZED BY Cardiology Division Garibaldi-Nesima Hospital SCIENTIFIC SECRETARIAT Michele M. Gulizia Cardiology Division Garibaldi-Nesima Hospital Via Palermo, Catania, Italy Phone Fax CONGRESS VENUE Sheraton Catania Hotel & Conference Center ORGANIZING SECRETARIAT Adria Congrex s.r.l. Via Sassonia, Rimini, Italy Phone Fax